Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy

Detalles Bibliográficos
Autores principales: Rinaldi, Francesca, Federle, Lisa, Puthenparampil, Marco, Perini, Paola, Grassivaro, Francesca, Gallo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Clinical/Scientific Notes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730817/
https://www.ncbi.nlm.nih.gov/pubmed/29259997
http://dx.doi.org/10.1212/NXI.0000000000000420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730817/
https://www.ncbi.nlm.nih.gov/pubmed/29259997
http://dx.doi.org/10.1212/NXI.0000000000000420

Ejemplares similares